Literature DB >> 31214784

Characterization and genome analysis of novel Klebsiella phage Henu1 with lytic activity against clinical strains of Klebsiella pneumoniae.

Tieshan Teng1, Qiming Li1,2, Zhengguo Liu1, Xianghui Li1, Zizheng Liu1, Hanshu Liu1, Fangyan Liu1, Longxiang Xie1, Huijuan Wang1, Lei Zhang1, Dongdong Wu1, Mingliang Chen1, Yanzhang Li3, Ailing Ji1.   

Abstract

Klebsiella pneumoniae is an important human pathogen that is associated with a wide range of diseases, including pneumonia and septicemia. Because of the threat of drug-resistant K. pneumoniae to humans, especially carbapenem-resistant K. pneumoniae, which is becoming a growing threat to hospitalized patients, the potential use of phage therapy has generated considerable interest. Henu1, isolated from a sewage sample, was identified as a linear double-stranded DNA phage of 40,352 bp with 53.14% G + C content and 143-bp terminal repeats. The Henu1 genome contains 45 open reading frames, and no tRNA genes were found. K. pneumoniae clinical strains with the capsular types K-1, K-2, and K-57 could be infected by Henu1. No human-virulence-related genes or lysogen-formation gene clusters were detected in this phage genome, suggesting that Henu1 is a virulent phage in its bacterial host and is safe for humans.

Entities:  

Mesh:

Year:  2019        PMID: 31214784     DOI: 10.1007/s00705-019-04321-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

1.  Novel Lytic Phages Protect Cells and Mice against Pseudomonas aeruginosa Infection.

Authors:  Feng Chen; Xingjun Cheng; Jianbo Li; Xiefang Yuan; Xiuhua Huang; Mao Lian; Wenfang Li; Tianfang Huang; Yaliu Xie; Jie Liu; Pan Gao; Xiawei Wei; Zhenling Wang; Min Wu
Journal:  J Virol       Date:  2021-01-20       Impact factor: 5.103

2.  Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics.

Authors:  Xianghui Li; Tongxin Hu; Jiacun Wei; Yuhua He; Abualgasim Elgaili Abdalla; Guoying Wang; Yanzhang Li; Tieshan Teng
Journal:  Antibiotics (Basel)       Date:  2021-02-09

3.  Identification of a Depolymerase Specific for K64-Serotype Klebsiella pneumoniae: Potential Applications in Capsular Typing and Treatment.

Authors:  Jiayin Li; Yueying Sheng; Ruijing Ma; Mengsha Xu; Fuli Liu; Rong Qin; Mingxi Zhu; Xianchao Zhu; Ping He
Journal:  Antibiotics (Basel)       Date:  2021-02-01

Review 4.  Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses.

Authors:  Warren P Herridge; Preetha Shibu; Jessica O'Shea; Thomas C Brook; Lesley Hoyles
Journal:  J Med Microbiol       Date:  2020-01-24       Impact factor: 2.472

5.  Characterization and Full Genome Sequence of Novel KPP-5 Lytic Phage against Klebsiella pneumoniae Responsible for Recalcitrant Infection.

Authors:  Ahmed R Sofy; Noha K El-Dougdoug; Ehab E Refaey; Rehab A Dawoud; Ahmed A Hmed
Journal:  Biomedicines       Date:  2021-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.